Precision in practice: GenAI in clinical trials

In the dynamic world of the healthcare industry, clinical research stands at the forefront of innovation, using emerging techniques and technologies to bring generation after generation of new therapies to patients around the world.

With the buzz around generative AI (GenAI) growing at a rate of knots, it is no surprise that one of the most promising areas for the technology is in clinical trials. GenAI’s prowess in data analysis, its ability to transform arduous tasks into actionable assets in a matter of mere seconds, has the potential to empower navigating information with unprecedented speed, ushering in a new era of expedited, data-driven clinical research.

“The clinical trial space is, as we all know, an area where we have a lot of repetitive and very time-consuming tasks,” explains Silvia De Carvalho, clinical studies lead at AXON. “GenAI is really a tool that enables an acceleration in some of these tasks, where before it would be a very manual prolonged process for both sponsors and sites.”

With nearly 20 years of experience in digital communication and engagement, De Carvalho understands the multifaceted influence generative AI presents, as well as the challenges that remain with fully realising this potential. Here, she discusses the use of GenAI in clinical trials, from data analysis to patient engagement.

• Read the full article in pharmaphorum's Deep Dive digital magazine